Le Lézard
Classified in: Science and technology
Subject: Award

Chartis Recognizes SymphonyAI with Inaugural "GenAI Initiatives Award" and Ranks SymphonyAI Among Top Three in Chartis Research Financial Crime and Compliance 50 Report


SymphonyAI, a leader in predictive and generative enterprise AI SaaS, today announced that it was recognized by industry researcher Chartis for gen AI innovation and financial crime and compliance capabilities. The Chartis GenAI Initiatives Award recognizes the strength of the SymphonyAI Sensa Investigation Hub and Sensa Copilot, which combine industry-leading predictive and generative AI with deep financial crime detection domain expertise. In addition, SymphonyAI is ranked among the top three vendors in the inaugural Chartis Financial Crime and Compliance 50 (FCC 50) Ranking.

The Chartis FCC report provides an in-depth analysis of vendors excelling in the realm of financial crime prevention and compliance. Leaders from the FCC 50 report were announced at the March 13 Financial Crime and Compliance 50 event. The Chartis FCC report provides precise insights relevant to specific aspects of the compliance solutions market. SymphonyAI received the top three ranking for its effectiveness in innovation, market responsiveness, and comprehensive solutions offerings.

At the core of SymphonyAI's financial crime prevention suite is the industry-leading generative and predictive AI Eureka architecture, a platform for ethical AI that utilizes built-in authentication, enterprise-class security and privacy, and robust authentication protections to enable secure collaboration. The combination of advanced generative and predictive AI technology and SymphonyAI's extensive global financial crime detection expertise means that SymphonyAI financial crime and compliance solutions deliver quantum leaps in productivity for financial crime investigators.

SymphonyAI's financial crime and compliance solutions reduce the complexities and costs financial institutions face in financial crime detection through AI, advanced risk detection, and alert management analytics. The Sensa Investigation Hub is a unified case management platform that consolidates risk for an enterprise-wide, entity-centric view across AML, KYC/CDD, screening, and payment fraud. As part of the Sensa Investigation Hub, the Sensa Copilot arms every investigator with a generative AI-powered assistant that can source, analyze, and summarize data at scale, accelerating investigation times by up to 70%. In addition, powerful SensaAI augmentations give AI upgrades to existing solutions, including AML and sanctions screening, evolving risk detection, and match accuracy without complex deployments.

"Financial crime bad actors are increasingly brazen and aggressive in their use of sophisticated technologies, including AI," said Nick Vitchev, research director at Chartis. "It's imperative that financial institutions keep pace by adopting technology that combines predictive and generative AI with rules-based guidelines to detect and prevent proliferating financial crime. SymphonyAI provides these capabilities through its Investigation Hub and Sensa Copilot, and continues to invest in predictive and generative AI innovation to ensure its global customers can combat financial crime effectively."

"I am delighted and excited with this recognition by Chartis in the new Financial Crime and Compliance 50 Ranking and the GenAI Initiatives Award for our powerful AI-led financial crime detection innovations," said Mike Foster, president of SymphonyAI's financial services division. "SymphonyAI's strong ranking reflects our relentless focus on giving financial institutions the power of leading predictive and generative AI technologies, including additional copilots soon to come to market. Our unparalleled technology leadership and deep financial crime detection domain knowledge are the foundation for a global customer base of hundreds of leading financial institutions. SymphonyAI's award-winning software and industry expertise position us to enable financial crime investigators worldwide to achieve astonishing efficiency and accuracy breakthroughs in crime detection and compliance."

About SymphonyAI

SymphonyAI is building the leading enterprise AI SaaS company for digital transformation across the most critical and resilient growth verticals, including retail, consumer packaged goods, financial services, manufacturing, media, and business IT. SymphonyAI verticals have many leading enterprises as clients. Since its founding in 2017, SymphonyAI has grown rapidly to 3,000 talented leaders, data scientists, and other professionals. SymphonyAI is an SAIGroup company, backed by a $1 billion commitment from Dr. Romesh Wadhwani, a successful entrepreneur and philanthropist.


These press releases may also interest you

at 12:10
Xsolla, a global video game commerce company, announces a new partnership with Curve Games, the award-winning London-based publisher of several notable independent games. The alliance will leverage Xsolla's Web Shop to support Curve Games in...

at 12:05
Mintegral, a programmatic subsidiary of leading advertising technology company Mobvista (1860.HK), has launched an advanced model for precise user acquisition (UA). The new model, Target CPE (Cost Per Engagement), helps advertisers achieve lifetime...

at 12:00
Ekinops (Euronext Paris: EKI) (ISIN: FR0011466069), a leading supplier of optical transport and enterprise connectivity solutions for telecom operators and enterprises, today announced that Orange Business has chosen Ekinops technology to launch its...

at 12:00
Trianz, a global digital transformation technology solutions and services firm, is thrilled to announce the appointment of Priyanshu Singh as its new VP & Chief of Staff. This strategic hire comes at a pivotal moment as Trianz continues to experience...

at 12:00
Marelli, a leading global mobility technology supplier, announced that Kelei Shen is assuming the role of Executive Vice President and President China effective July 1, 2024. He will lead Marelli's ambitious growth plans for China....

at 11:56
Northwest Biotherapeutics ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, reported positive results of voting at the Annual Shareholders Meeting on June 29, 2024. ...



News published on and distributed by: